fenebrutinib

News mentioning fenebrutinib · Wikidata · RSS

Top stories

Latest

1. FDA Grants Priority Review to Fenebrutinib for Relapsing and Progressive MSneurologyadvisor.com · 2026-09-30 15:54 UTC · 1 more reports
2. Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosisGlobeNewswire — all · 2026-09-30 05:00 UTC · 3 more reports